Fresh Perspectives

Medical and Life Sciences

RPC's Medical / Life Sciences team tracks the critical societal, industrial and legal developments affecting risk management in the medical and life sciences sectors.

Untinted 1 wide
Blog

The government responds to Cumberlege - What now for product liability risks in the life sciences sector?

Topic: Medical and Life Sciences 26.07.2021 Read more
Blog

Life sciences and the Brexit trade agreement of Christmas Eve 2020

Topic: Medical and Life Sciences 26.03.2021 Read more
Abstract building
Blog

Covid-19 vaccines: an injection of politics

Topic: Medical and Life Sciences 07.01.2021 Read more
Blog

The Nocebo Effect: study into statins signals a timely warning

Topic: Medical and Life Sciences 17.11.2020 Read more
Purple tint 3
Blog

Buyer Beware: NHSX Guidance on Artificial Intelligence

Topic: Medical and Life Sciences 15.10.2020 Read more
Purple tint 2
Blog

Parents contest NICE Cannabis Guidelines at Court

Topic: Medical and Life Sciences 16.09.2020 Read more
Purple tint 4 wide
Blog

Beyond the fruit and yoga: surviving or thriving?

Topic: Medical and Life Sciences 16.06.2020 Read more
Exterior and sunset
Blog

Back to the Future: a look ahead at medical malpractice issues for COVID-19-related claims

Topic: Medical and Life Sciences

Published by James Davies, Senior Associate

Future issues for Insurers to consider in assessing COVID-19 medical malpractice / clinical negligence claims.

15.04.2020 Read more
Blog

SC double decision on vicarious liability

Topic: Medical and Life Sciences 03.04.2020 Read more
Exterior and sunset
Blog

COVID-19: the battle between fact and fiction

Topic: Medical and Life Sciences

Published by Emma Kislingbury, Senior Associate

In the era of fake news, and at a time of global panic, how is the government responding to the daily spread of unauthorised health claims around COVID-19?

01.04.2020 Read more